• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Hans-Christoph Diener - Articles and news items

Boehringer Ingelheim logo

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

Industry news / 8 May 2014 / Boehringer Ingelheim

Details of a new 6,000 patient study of dabigatran etexilate were announced at the European Stroke Conference, Nice, France…

Boehringer Ingelheim logo

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

Industry news / 7 May 2014 / Boehringer Ingelheim

Details of a new 6,000 patient study of dabigatran etexilate were announced at the European Stroke Conference…

Boehringer Ingelheim logo
Boehringer Ingelheim logo

Clinical experience with Pradaxa® crosses one million patient-years of treatment

Industry news, News / 27 August 2012 / Boehringer Ingelheim

40,000 people estimated to be saved from a stroke related to non-valvular atrial fibrillation…

Boehringer Ingelheim logo

FDA affirms superiority of Pradaxa® (dabigatran etexilate) 150mg over warfarin in reduction of both ischaemic and haemorrhagic strokes

Industry news, News / 6 June 2012 / Boehringer Ingelheim

Boehringer Ingelheim has updated the US prescribing information for Pradaxa®…

Boehringer Ingelheim logo

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +